女性生殖道解脲支原体感染与细菌性阴道病关系的研究
摘要
解脲支原体(Uu)感染、细菌性阴道病(BV)都是常见的导致女性泌尿生殖道炎症的重要原因。为了探讨二者的相关性,我们对2008年6月-2009年1月到吉林大学第一医院皮肤病性病门诊就诊的1491例患者进行了Uu、BV的检测,并同时检测Mh、NG、CT、念珠菌及阴道毛滴虫。其中Uu阳性者共696例,BV247例,Mh111例,NG10例,CT19例,念珠菌阳性者201例,阴道毛滴虫阳性者5例。其中Uu合并BV阳性者156例,Uu合并Mh阳性者89例,Uu合并NG者3例,Uu合并CT者11例,Uu合并念珠菌阳性者78例。Uu阳性的696例纳入观察组,合并BV阳性的为156例,Uu阴性的795例作为对照组,合并BV阳性的为91例,两组比较,观察组BV的阳性率(22.41%)明显高于对照组BV的阳性率(11.45%),差异有显著性(P<0.01),Uu感染者更易患细菌性阴道病。观察组BV的阳性率先随着年龄的增加而增高,31-40岁左右到达高峰,随后又随着年龄的增长而降低,对照组中BV的阳性率随着年龄的增长而降低,与年龄呈负相关。观察组与对照组相比,以21-30岁组和31-40岁组BV的阳性率高于对照组中BV的阳性率(P<0.01),差异有显著性。职业分布在两组间差异无显著性。观察组中采用屏障避孕法BV的检出率明显比非屏障避孕法低。对照组中各避孕方式间无明显差别。观察组BV阳性患者以阴道清洁度Ⅲ度和阴道清洁度Ⅳ度为主,对照组中BV患者以阴道清洁度Ⅱ度为主。所以,女性生殖道Uu感染可以增加BV的发病率;女性生殖道Uu感染与BV之间存在相关性;屏障避孕法可以降低Uu患者BV的发病率;女性生殖道Uu感染合并BV感染时,阴道清洁度下降。
Infection of ureaplasma urealyticum and bacterial vaginosis are two common reasons in the consequence of women urogenital inflammation. Uu has two serotypes, one is parvum biovar, and the other is urealyticum biovar. In many healthy women, Uu has the existence of asymptomatic carrier status in reproductive tract; when Uu colonization reaches a certain number or the serotype is pathogenic, clinical symptoms appear. In women, the organism can cause urinary tract inflammation, infertility, while in the pregnant ones, it may results in miscarriage, premature delivery, stillbirth, intrauterine growth retardation, premature rupture of membranes, low birth weight, and other development disoders, after delivery by transmission from mother to newborn, can cause neonatal diseases, too. Uu can be transmitted by sexual contact, which can also get the partner infected and the corresponding clinical syptoms, accordingly it’s classified to sexually trasimmited diseases. GV is the major pathogens to BV. There are normal floras in women’s vagina, which contributes a natural biological barrier. Any reason that can reduce the lactobacilli and disturb the environment of flora may help increasing the number of GV. BV can cause cervicitis, pelvitic inflammatory diseases and salpingitis, also may cause adverse pregnancy and neonatal sepsis. The reason that cause the disturbance of vaginal flora, such as, menstrual cycle, hormone levels in vivo, with other infections, sexual activity, ways of contraception, using of antibiotics, et al. Although BV is still not classified as sexually transmitted disease, it can be transmitted by sexual contact..
Uu is the most common pathogen of women STD--non-gonococcal cervicitis, while BV is common in vaginitis. In Vogel’s research, he found that, Uu is a independent factor of fetal growth and lowbirth weight, combined BV can worsen the consequence. However, we can hardly find research about the clinical relevance of Uu and BV. In the refractory infection of Uu, also the recurrent infection ones, is there a part that BV takes in, by means of changing the normal vaginal flora, damaging the vagina’s natural barrier, getting Uu infection more easier. What kind of relationship between them, In order to explore the correlation between them, we enrolled 1491 cases female patients who came to Dermatology and Sexually transimitted disease outpatient of The First Hospital of Jilin University, testing them for Uu,Mh,BV,NG,CT,Candida albicans and Trichomoniasis. Through the analysis of BV positive cases in both Uu positive group and Uu negative group; meanwhile, compare Uu positive cases in both BV positive and BV negative group.
ALL selected cases were female, with clinically increased vaginal discharege, smelly leucorrhea, lower abdominal discomfort, genital itching and other symptoms. They should have no administration of antibio tics sutemicly and locally in 2 weeks before, no sex in 3 days. The cases who had organic disease of the urogenital system, in the menstral period, pregnancy breast-feeding, have IUD, as well as the ones who did wash the vagina in 3 days, were excluded. A total of 1491 cases of selected cases, aged 20 to 56 years old, average 35.5 years old, with history duration 2 weeks to 2years, average 3 months. We get swab from posterior formix vaginal secretions in all cases for Trichomonas vaginalis and Candida detection, swab from cervix secretions for testing Uu,Mh,CT,NG.
Results: We detect 696 cases Uu positive patients, 247 cases for BV, 111 cases for Mh,10cases for NG, 19 cases for CT, 201 cases for fungus and 5 cases for trichomoniasis. In Uu positive cases, there are 156 BV positive cases, 89 Mh positive cases, 3 NG positive cases, 11 CT positive cases, and 78 Candida-positive cases. In the 696 cases Uu positive group, we have 156 cases who with BV positive, either; in the 795 cases Uu negative group, we get 91 cases with BV positive, the rate of BV positive in Uu positive group(22.41%) is higher than that in Uu negative group(11.45%), P<0.01. In the 21-30-year-old group and 31-40 year-old-group, the rate of BV positive in the observer group is higher than that of control group. There is no significant difference of occupational distribution in the two groups. Using of barrier contraception can significantly low down the BV positive rate than non-barrier contraception, while the control group has no significant difference in contraceptive methods. The vaginal sanitary degree areⅢ,Ⅳin observation group,Ⅱin control group.
Conclusions: People who gets Uu infection is easy to get BV. There is relevance between Uu infection and BV. Barrier contraception can reduce the Uu infection and incidence of BV. Vaginal sanitary degree declines in co-infection of Uu and BV patients.
Infection of ureaplasma urealyticum and bacterial vaginosis are two common reasons in the consequence of women urogenital inflammation. Uu has two serotypes, one is parvum biovar, and the other is urealyticum biovar. In many healthy women, Uu has the existence of asymptomatic carrier status in reproductive tract; when Uu colonization reaches a certain number or the serotype is pathogenic, clinical symptoms appear. In women, the organism can cause urinary tract inflammation, infertility, while in the pregnant ones, it may results in miscarriage, premature delivery, stillbirth, intrauterine growth retardation, premature rupture of membranes, low birth weight, and other development disoders, after delivery by transmission from mother to newborn, can cause neonatal diseases, too. Uu can be transmitted by sexual contact, which can also get the partner infected and the corresponding clinical syptoms, accordingly it’s classified to sexually trasimmited diseases. GV is the major pathogens to BV. There are normal floras in women’s vagina, which contributes a natural biological barrier. Any reason that can reduce the lactobacilli and disturb the environment of flora may help increasing the number of GV. BV can cause cervicitis, pelvitic inflammatory diseases and salpingitis, also may cause adverse pregnancy and neonatal sepsis. The reason that cause the disturbance of vaginal flora, such as, menstrual cycle, hormone levels in vivo, with other infections, sexual activity, ways of contraception, using of antibiotics, et al. Although BV is still not classified as sexually transmitted disease, it can be transmitted by sexual contact..
Uu is the most common pathogen of women STD--non-gonococcal cervicitis, while BV is common in vaginitis. In Vogel’s research, he found that, Uu is a independent factor of fetal growth and lowbirth weight, combined BV can worsen the consequence. However, we can hardly find research about the clinical relevance of Uu and BV. In the refractory infection of Uu, also the recurrent infection ones, is there a part that BV takes in, by means of changing the normal vaginal flora, damaging the vagina’s natural barrier, getting Uu infection more easier. What kind of relationship between them, In order to explore the correlation between them, we enrolled 1491 cases female patients who came to Dermatology and Sexually transimitted disease outpatient of The First Hospital of Jilin University, testing them for Uu,Mh,BV,NG,CT,Candida albicans and Trichomoniasis. Through the analysis of BV positive cases in both Uu positive group and Uu negative group; meanwhile, compare Uu positive cases in both BV positive and BV negative group.
ALL selected cases were female, with clinically increased vaginal discharege, smelly leucorrhea, lower abdominal discomfort, genital itching and other symptoms. They should have no administration of antibio tics sutemicly and locally in 2 weeks before, no sex in 3 days. The cases who had organic disease of the urogenital system, in the menstral period, pregnancy breast-feeding, have IUD, as well as the ones who did wash the vagina in 3 days, were excluded. A total of 1491 cases of selected cases, aged 20 to 56 years old, average 35.5 years old, with history duration 2 weeks to 2years, average 3 months. We get swab from posterior formix vaginal secretions in all cases for Trichomonas vaginalis and Candida detection, swab from cervix secretions for testing Uu,Mh,CT,NG.
Results: We detect 696 cases Uu positive patients, 247 cases for BV, 111 cases for Mh,10cases for NG, 19 cases for CT, 201 cases for fungus and 5 cases for trichomoniasis. In Uu positive cases, there are 156 BV positive cases, 89 Mh positive cases, 3 NG positive cases, 11 CT positive cases, and 78 Candida-positive cases. In the 696 cases Uu positive group, we have 156 cases who with BV positive, either; in the 795 cases Uu negative group, we get 91 cases with BV positive, the rate of BV positive in Uu positive group(22.41%) is higher than that in Uu negative group(11.45%), P<0.01. In the 21-30-year-old group and 31-40 year-old-group, the rate of BV positive in the observer group is higher than that of control group. There is no significant difference of occupational distribution in the two groups. Using of barrier contraception can significantly low down the BV positive rate than non-barrier contraception, while the control group has no significant difference in contraceptive methods. The vaginal sanitary degree areⅢ,Ⅳin observation group,Ⅱin control group.
Conclusions: People who gets Uu infection is easy to get BV. There is relevance between Uu infection and BV. Barrier contraception can reduce the Uu infection and incidence of BV. Vaginal sanitary degree declines in co-infection of Uu and BV patients.
引文
[1] Shepard M .Am J Syph [J].1954, 38:113-114.
[2] Robertson JA, Stemke GW.Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans[J] .J Clin Microbiol,1982,15:873–878.
[3]马书军,赵庆伟,张英奎等.1306例妇女生殖道感染性疾病及危险因素调查[J] .河北医药,2006,28(5):288-389.
[4]王晓彦,王涛,刘玉秀等.内蒙地区妊娠妇女阴道分泌物解脲支原体生物群和血清型的检测[J] .中国实用妇科与产科杂志,2000,16(1):47-48.
[5] JensenJS,UidumSA,Sondergard-nderson J,et al.Polymerase chain reaction for detection of mycoplasma genitalium in clinical samples[J] . JClin- Microbil,1991,29:46.
[6] P. Christopoulos,E. Deligeoroglou,K. Papadias.Genital mycoplasmas in non-sexually active young females with vaginal discharge[J] .International Journal of Gynecology & Obstetrics,2007,97(1):49-50.
[7]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[8]陆春,朱国兴,黄怀球.解脲支原体对子宫颈致病性的临床分析[J] .临床皮肤科杂志,2002,31(3):149-150
[9]张胜娣.解脲支原体感染因素调查和防治对策研究[J] .中国初级卫生保健,2007,21(1):93.
[10]徐小平,李卓成,艾辉,等.解脲支原体分群分型在妇女非淋菌性尿道炎诊断中的应用[J] .中国现代医学杂志,2007,17(21):2647-2650.
[11] Yoshida T,Ishiko H,Yasuda M.Polymerase chain reaction based subtyping of ureaplasma parvum and ureaplasma urealyticum in firstpass urinesamples from men with or without urethritis[J] .Sex Transm Dis,2005,32(7):454 - 457.
[12] Vikas Gupta,Benu Dhawan, Neena Khanna,et al.Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections[J] .Diagnostic Microbiology and Infectious Disease,2008,60(1):95-97.
[13] Abel E-Hom M,Scholz M,Wolff C,et al.High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery[J] .Acta Obstet Gynecol Scand ,2000,79(11):973 - 978.
[14] Chaim W,Horowitz S,Vavid J B,et al.Ureaplasma urealyticum in the development of postpartum endometritis[J] .Eur J Obstet Gynecol Reprod Biol,2003,109((2):145 - 148.
[15]张帝开,覃春容,李秀云,等.女性下生殖道解脲支原体的定量检测与致病性研究[J] .中国实用妇科与产科杂志,2005,21 (11):656 -658.
[16] Hashimoto O,Yoshida T,Ishiko H,et al.Quantitive detection and phylogeny - based identification of mycoplasmas and ureaplasmas from human immunodeficiency virus type 1 - positive patients[J] .J Infect Chemother,2006,12(1):25 - 30.
[17]李冬梅,杨彦玲,劳创能,等.孕妇沙眼衣原体及解脲支原体感染的相关因素研究[J] .中国优生与遗传杂志,2006,14(6):67-69.
[18]汪宁,赵季文,徐草瑜,等.生殖道解脲支原体感染症流行因素分析[J] .中国公共卫生,1994,10(4):147-149.
[19]杨建宏,王荣,王伟明,等.解脲支原体感染非淋菌性尿道炎大鼠模型建立及评价[J] .中药药理与临床,2008,24(5):76-78.
[20]李园,王志萍,李众玲,等.解脲支原体和人型支原体与非淋菌性尿道炎的调查[J] .实用医学进修杂志,2006,34(3):179-182
[21]徐小平,李卓成,艾辉,等.解脲支原体致非淋菌性尿道炎的研究[J] .中国卫生检验杂志,2005,15(9):1116-1117.
[22] Jennette M,PottsA,Michele Ward,Raymond R,Rackley.Association of Chronic Urinary Symptoms In Women And Ureaplasma urealy- ticum[J] . Urology,2000,55(4):486-489.
[23]李华,张洪文. .不同浓度解脲支原体血清型3在小鼠模型中的致病性研究[J] .中南大学,2008.
[24]江秀梅.178例阴道炎、宫颈炎患者解脲支原体感染状况分析[J] .疾病监测,2002,17(9):333.
[25]毛文奇.宫颈炎合并接触性出血与解脲支原体、沙眼衣原体感染的关系[J] .现代诊断与治疗,2005,16(6):362.
[26]张月莲,杨燕生.解脲支原体感染与输卵管性不孕的关系[J] .中华妇产科杂志,2000,35(2):110-111.
[27] PrabhakarK,SubramanianS,Thyagarajan SP.Mycoplasmahominis in pelvic inflammatory disease[J] .Indian J PatholMicrobiol,1994,37(3):293-298.
[28]刘建玲.慢性盆腔炎与沙眼衣原体及解脲支原体感染的关系[J] .临床心身疾病杂志,2007,13(3):252-253.
[29]黄跃深,黄志宏,王群,等.350例盆腔炎患者解脲支原体感染情况分析[J] .岭南皮肤性病科杂志,2006,13(2):94-95.
[30]韩茜,李秀荣,于占林等.不孕妇女生殖道支原体感染情况及药敏分析[J] .中国优生与遗传杂志.2004,12(5):122-123.
[31]陈永坚.不孕症妇女沙眼衣原体、解脲支原体感染的临床分析[J] .中国社区医师,2005,7(120):31.
[32]顾志芬.不孕不育妇女宫颈拭子解脲脲原体和人型支原体检测[J] .现代实用医学,2001,13(12):605.
[33] McGregor JA.French J I.Chlamydia trachomatis infection during pregnancy.Am J Obstet Gynecol,1991,6:1782-1789.
[34]张红霞,马远芳.解脲支原体感染与自然流产的关系[J] .中原医刊,1997,24(8):2-3.
[35] DesilvaN s,Quinn PA.Endogenous activity of phospholipaseA and C in ureaplasma urealyticum. J ClinMicrobiol,1986,23:354-359.
[36]潭巨莲,李进,孙辉臣,等.石家地区73例羊水解脲脲原体分离培养结果与临床分析[J] .中国优生与遗传杂志,1999,7(1):76 - 77.
[37] Lieselotte Kirchner,Hanns Helmer,Georg Heinze,et al.Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants[J] .European Journal of Obstetrics & Gynecology and Reproductive Biology,2007,134:44-50.
[38] Embree JE,Krause VW,Embil VA,et al.Placental infection with mycopasma hom inis and urealyticum: clinical correction.Obstet Gynecol,1980,56:475-481.
[39]刘子韬,李丽娜,王俊松.宫内解脲支原体感染与新生儿出生体重[J] .白求恩医科大学学报,1998,24(5):482-484.
[40] A. Rempen , J. Martius,A. Hartmannet al.Transmission Rate of Ureaplasma Urealyticum,Mycoplasma spp,Gardnerella Vaginalis,B-Streptococci,Candida spp. and Chlamydia Trachomatis from the Mother to the Newborn.Arch Gynecol Obstet,1987,241:165-170.
[41] Stagno S, Brasfield DM, Brown MB, Cassell GH, Pifer LL, Whitley RJ, Tiller RE Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics,1981,68:322-329.
[42] Cassell, G. et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns[J]. Clin. Microbiol, 1993,69-87.
[43]赵辨.《临床皮肤病学》(第三版).江苏:江苏科技出版社,2001,1106.
[44]范梦麟,唐孝亮,液体培养基培养解脲支原体效果评价[J].湖南医学高等专科学校学报,2001,3(1):24-25.
[45]陈志和,罗迪青,赖小敏.间接免疫荧光法检测解脲支原体[J].中国优生与遗传杂志,.2001,9(4):103-107.
[46]徐晨,钱黎华,王侠生等.培养及PCR法检测泌尿生殖道解脲支原体比较[J] .中国皮肤性病学杂志,1998,12(5):270-271.
[47]邱东海,徐静,汪秀荣.PCR杂交梳与培养检测解脲支原体的比较[J] .赣南医学院学报,2001,21(4):382-383.
[48]黄长征,林能兴,涂亚庭.阿奇霉素、氧氟沙星联合治疗解脲支原体所致非淋菌性尿道炎疗效观察[J] .华中医学杂志,2005,29(3):165-166.
[49]吴晓梅,戈静,余韬.纳米银与四环素联合治疗女性生殖道解脲支原体感染疗效观察[J] .中国妇产科临床杂志,2006,7(5):366.
[50]毛惠,戴晓蓉,詹平.中药内服外洗治疗妊娠中晚期解脲支原体感染60例[J] .中国中西医结合杂志,2006,26(7):663-665.
[51]郑华,钟淑霞,李明成.白头翁素联合铜绿治疗解脲支原体性非淋菌性尿道炎[J] .山东医药,2006,46(27):17-18.
[52]姜淑芬.奥平栓治疗支原体、衣原体感染及慢性宫颈炎的临床观察[J] .实用妇产科杂志,1998,14(3):163.
[53]王勤超,牛金波.交沙霉素联用重组人干扰素α-2b栓治疗解脲支原体感染性宫颈炎临床观察[J] .中国乡村医药杂志,2007,14(8):24.
[54] Jeff Wang.Bacterial Vaginosis[J] .Elsevier Science Inc,2000,7(5):181-185.
[55] Gardner HL,Dukes CD.Haemophilus vaginalis . A newly defined specificinfection previously classified ''Nonspecific'' vaginitis. Am J Obstet Gynecol,1955,69:962-76.
[56]樊尚荣,刘小平.细菌性阴道病的研究进展[J] .中国妇产科临床杂志,2006,7(3):224-226.
[57] Eschenbach DA,Davick PR,Williams BL,Klebanoff SJ,et al . Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis[J]. J Clin Microbiol,1989,27:251-6.
[58] Kimerlin DF,Andrews WW. Bacterial vaginosis: association with adverse pregnancy outcome[J]. SeminPerinatol,1998,22(4):1- 8.
[59]多丽波,郭薇媛,陈会.阴道加德纳菌[J] .哈尔滨医科大学学报,1998,32(1):76-79
[60]吴爱武,曹锦洪,刘岩平.阴道加德纳菌和细菌性阴道病相关性研究.临床皮肤科杂志,2000,29:324 - 325.
[61] Scott TG,Smyth CJ,Keane CT. In vitro adhesiveness and biotype of Gardnerella vaginalis strains in relation to the occurrence of clue cells in vaginal discharges.Genitourin Med,1987,63:47-53.
[62] Sobel JD. Vaginitis. New Engl J Med,1997,337:1896-903.
[63] Saidi SA,Mandal D,Curless E. Bacterial vaginosis in a district genitourinary medicine department: Significance of vaginal microbiology and anaerobes. Int J STD AIDS,1994,5:405-8.
[64] Mardh PA. The definition and epidemiology of bacterial vaginosis[J]. Rev Fr Gynecol Obstet,1993,88:195-7.
[65] Schoonmaker JN,Lunf BD,Lawellin DW,et al.A new proline aminopeptidase assay for diagnosis of bacterial vaginosis[J] .Am J Obstet Gynecol,1991,165:737.
[66] Ness RB,Hillier S,Richter HE,et al.Can known risk factors explain racialdifference in the occurrence of bacterial vaginosis[J] .J Natl Med Assoc,2003,95(3):201 - 212.
[67] Chiaffarino F,Parazzin I F,DeBesiP,et al.Risk factors for bacterial vaginosis [J] . Reprod Biol,2004,117(2):222-226.
[68]陈会波,周兰英,李会庆等.山东省农村地区已婚育龄妇女细菌性阴道病患病现状及危险因素[J] .国医学科学院学报,2006,28(3):378-381.
[69]毛淑芳,高玉峰.细菌性阴道病的危险因素研究现状[J] .中国公共卫生,2004,20(6):756-757.
[70] Alnaif B,Drutz HP.Bacterial vaginosis increase in pessary users[J] . Int Urogynecol J Pelvic Floor Dysfunct,2000,11(4):219 - 222.
[71] Hellberg D,Nilsson S,Mardh PA.Bacterial vaginosis and smoking[J] . Int J STD AIDS,2000,11(9):603 - 606.
[72] King EA,Britt R,McFarlane JM,et al.Bacterial vaginosis and chlamydia trachmatis among pregnant abused and nonabused His-panic women [J] . J Obste Gynecol Neonatal Nurs,2000,29(6):606 - 612.
[73]毛淑芳,金凤表,刘岩.产前检查妇女细菌性阴道病的筛检和相关危险因素的研究[J] .现代预防医学,2006,33(10):769-1771.
[74] Calzolari E,Masciangelo R,Milite V,et al.Bacterial vaginosis and contraceptive methods.Int J Gynecol Obstet,2000,70(3):341–346.
[75] Joesoef MR,Karundeng A,Runtupalit C,et al.High rate of bacteria vaginosis among women with intrauterine devices in Manado,Indonesia [J] . Contraception ,2001 ,64 (3) :169 - 172.
[76] Hodolugil NNS,Aslan D,Bertan M.Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence [J] . Contraception,2000,61(6):359 - 364.
[77] Morris MC,Rogers PA,Kinghorn GR,Is bacterial vaginosis a sexuallytransmitted infection [J] . Sex Transm Infect,2001,77(1):63 - 68.
[78] Kamara P,HyltonKong T,Brathwaite A,et al. Vaginal infections in pregnant women in Jamaica :prevalence and risk factors[J] . Int J STD AIDS,2000 ,11(8):516 - 520.
[79]俞树荣.微生物学和微生物学检验[M] .北京:人民卫生出版社,1997,263– 264.
[80] Spiegel CA, Amsel R, Holmes KR.Diagnosis of bacterial vaginosis is improved by direct gram stain of vaginal fluid. J Clin Microbiol,1983,18:170–7.
[81] Howe L,Wiggins R,Soothill PW,et al. Mueinase and sialidase activity of the vaginal microfilaria: imp lications of thepathogenesis of p reterm labour. Int J STD A IDS,1999,10(7):442-447.
[82]张卫英,项国谦,陈岳明等.BV Blue快速检测法对细菌性阴道病的诊断价值[J].浙江中西医结合杂志,2006,16(2):92-93.
[83]刘俊梅,杨文东,杨进国.快速脯氨酸氨基肽酶与唾液酸酶检测在细菌性阴道病诊断中的对比研究[J].中国妇产科临床杂志,2006,79(1):45-46.
[84]张海霞.细菌性阴道病的诊治进展[J].河北医药,2002,24(7):589-599.
[85] Amsel R, Totten PA, Spiegel CA.Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med,1983,74:14-22.
[86] Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by astandardized method of Gram stain interpretation. J Clin Microbiol,1991,29:297–301.
[87] Hillier SL. Diagnostic microbiology of bacterial vaginosis[J]. Am J Obstet Gynecol,1993,169:455–9.
[88] Morales WJ, Schorr S, Albritton J.Effect of metronidazole in patients withpreterm birth in preceding pregnancy and bacterial vaginosis:a placebo- controlled, double-blind study. Am J Obstet Gynecol,1994,171:345–9.
[89] Platz-Christensen JJ, Brandberg A, Wiqvist N. Increased prostaglandin concentrations in the cervical mucosa of pregnant women with bacterial vaginosis. Prostaglandins,1992,43:133-4.
[90] Cauci S , Hitti J , Noonan C , et al. Vaginal hydrolytic enzymes , Immunoglobulin A against Gardnerella vaginalis toxin , and risk of earlypreterm birth among women in preterm labor with bacterial vaginosis or intermediate flora[J] .1 AmJ Obstet Gynecol,2002,187:877-881.
[91] Carney FE.Haemophilus vaginalis septicaemia.Obstet Gynecol,1973,41:78-79.
[92] Gregory T Spear,Elizabeth St John,M Reza Zariffard.Bacterial vaginosis and human immunodeficiency virus infection[J].AIDS Research and Therapy 2007,4:25.
[93]张宣东,李光明,翁婉波。细菌性阴道病的发病情况及其诊断[J].海军医学杂志,2000,21(3):232-234.
[94]袁会敏,卞国玲,蒋丽娜.定君生与甲硝唑治疗细菌性阴道病的临床比较[J] .中国微生态学杂志,2006,18(3):251.
[95]石江平.α-干扰素栓治疗细菌性阴道病118例疗效观察[J] .实用临床医学,2006,7(1):90.
[1]曹玉璞,叶元康.支原体与支原体病[M].北京:人民卫生出版社, 2000.
[2] Vul,vovic luv,Rakovskaia IV,Gamova NA. The laboratory diagnosis of mycoplasmosis and ureaplasmosis in urological and gyneco- logicl patients [J]. Zh Mikrobial Epidemiol ,1995,5 :97
[3]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[4] Yoshida T , Ishiko H ,Yasuda M. Polymerase chain reaction based subtyping of ureaplasma parvum and ureaplasma urealyticum in firstpass urine samples from men with or without urethritis[J] . Sex Transm Dis,2005,32(7):454 - 457.
[5] Vikas Gupta,Benu Dhawan,Neena Khanna,et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections[J] . Diagnostic Microbiology and Infectious Disease,2008,60(1):95-97.
[6] Abele-Hom M,Scholz M,Wolff C,et al. High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery[J] . Acta Obstet Gynecol Scand,2000,79 (11):973 - 978.
[7] Chaic W,Horowitz S,Vavid J B,et al. Ureaplasma urealyticum in the development of postpartum endometritis[J] . Eur J Obstet Gynecol Reprod Biol,2003,1099(2):145 - 148.
[8]张帝开,覃春容,李秀云,等.女性下生殖道解脲支原体的定量检测与致病性研究[J] .中国实用妇科与产科杂志,2005,21(11):656 -658.
[9]樊尚荣,刘小平.细菌性阴道病的研究进展[J] .中国妇产科临床杂志,2006,7(3):224-226.
[10] Sobel JD.Vaginitis. New Engl J Med,1997,337:896-903.
[11] Carney FE.Haemophilus vaginalis septicaemia. Obstet Gynecol. 1973,41:78-79.
[12] Chiaffarino F,Parazzini F,De BesiP,et al. Risk factors for bacterial vaginosis [J] . REPROD. BIOL, 2004,117(2):222-226.
[13]陈会波,周兰英,李会庆等.山东省农村地区已婚育龄妇女细菌性阴道病患病现状及危险因素[J] .中国医学科学院学报,2006,28(3):378-381.
[14]毛淑芳,高玉峰.细菌性阴道病的危险因素研究现状[J] .中国公共卫生,2004,20(6):756-757.
[15] Alnaif B,Drutz HP. Bacterial vaginosis increase in pessary users[J] . Int Urogynecol J Pelvic Floor Dysfunct,2000,11(4):219 - 222.
[16] Hellberg D,Nilsson S,Mardh PA. Bacterial vaginosis and smoking[J] . Int J STD AIDS,2000,11(9):603 - 606.
[17] King EA,Britt R,McFarlane JM, et al. Bacterial vaginosis and chlamydia trachmatis among pregnant abused and nonabused His-panic women [J].J Obste Gynecol Neonatal Nurs,2000,29(6):606 - 612.
[18] Calzolari E,Masciangelo R,Milite V,et al. Bacterial vaginosis and contraceptive methods.Int J Gynecol Obstet,2000,70(3):341–346.
[19] Kamara P,HyltonKong T,Brathwaite A,et al. Vaginal infections in pregnant women in Jamaica :prevalence and risk factors[J] .Int J STD AIDS,2000,11(8):516 - 520.
[20]李沂轩,纪岩文.阴道加德纳菌的研究现状[J] .中国麻风皮肤病杂志,2006,22(4):319-321.
[21] Scott TG,Smyth CJ,Keane CT. In vitro adhesiveness and biotype of Gardnerella vaginalis strains in relation to the occurrence of clue cells invaginal discharges. Genitourin Med,1987,63:47-53.
[22] Mcgregor JA. Premature rupture of membranes and bacterial vaginosis [J] .Am Obstet Gynecol,1993,169:463.
[23]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[24]刘志强,张玲华,谷学英等.不同育龄妇女人群细菌性阴道病调查及临床分析[J].中国妇幼保健,2005,20:1394-1396.
[25] Dacca KR. Mycoplasma arthritidised derived superantigens induces proinflammatory monocytic cell live. Infection and Immunity,1994,62(6):2049.
[2] Robertson JA, Stemke GW.Expanded serotyping scheme for Ureaplasma urealyticum strains isolated from humans[J] .J Clin Microbiol,1982,15:873–878.
[3]马书军,赵庆伟,张英奎等.1306例妇女生殖道感染性疾病及危险因素调查[J] .河北医药,2006,28(5):288-389.
[4]王晓彦,王涛,刘玉秀等.内蒙地区妊娠妇女阴道分泌物解脲支原体生物群和血清型的检测[J] .中国实用妇科与产科杂志,2000,16(1):47-48.
[5] JensenJS,UidumSA,Sondergard-nderson J,et al.Polymerase chain reaction for detection of mycoplasma genitalium in clinical samples[J] . JClin- Microbil,1991,29:46.
[6] P. Christopoulos,E. Deligeoroglou,K. Papadias.Genital mycoplasmas in non-sexually active young females with vaginal discharge[J] .International Journal of Gynecology & Obstetrics,2007,97(1):49-50.
[7]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[8]陆春,朱国兴,黄怀球.解脲支原体对子宫颈致病性的临床分析[J] .临床皮肤科杂志,2002,31(3):149-150
[9]张胜娣.解脲支原体感染因素调查和防治对策研究[J] .中国初级卫生保健,2007,21(1):93.
[10]徐小平,李卓成,艾辉,等.解脲支原体分群分型在妇女非淋菌性尿道炎诊断中的应用[J] .中国现代医学杂志,2007,17(21):2647-2650.
[11] Yoshida T,Ishiko H,Yasuda M.Polymerase chain reaction based subtyping of ureaplasma parvum and ureaplasma urealyticum in firstpass urinesamples from men with or without urethritis[J] .Sex Transm Dis,2005,32(7):454 - 457.
[12] Vikas Gupta,Benu Dhawan, Neena Khanna,et al.Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections[J] .Diagnostic Microbiology and Infectious Disease,2008,60(1):95-97.
[13] Abel E-Hom M,Scholz M,Wolff C,et al.High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery[J] .Acta Obstet Gynecol Scand ,2000,79(11):973 - 978.
[14] Chaim W,Horowitz S,Vavid J B,et al.Ureaplasma urealyticum in the development of postpartum endometritis[J] .Eur J Obstet Gynecol Reprod Biol,2003,109((2):145 - 148.
[15]张帝开,覃春容,李秀云,等.女性下生殖道解脲支原体的定量检测与致病性研究[J] .中国实用妇科与产科杂志,2005,21 (11):656 -658.
[16] Hashimoto O,Yoshida T,Ishiko H,et al.Quantitive detection and phylogeny - based identification of mycoplasmas and ureaplasmas from human immunodeficiency virus type 1 - positive patients[J] .J Infect Chemother,2006,12(1):25 - 30.
[17]李冬梅,杨彦玲,劳创能,等.孕妇沙眼衣原体及解脲支原体感染的相关因素研究[J] .中国优生与遗传杂志,2006,14(6):67-69.
[18]汪宁,赵季文,徐草瑜,等.生殖道解脲支原体感染症流行因素分析[J] .中国公共卫生,1994,10(4):147-149.
[19]杨建宏,王荣,王伟明,等.解脲支原体感染非淋菌性尿道炎大鼠模型建立及评价[J] .中药药理与临床,2008,24(5):76-78.
[20]李园,王志萍,李众玲,等.解脲支原体和人型支原体与非淋菌性尿道炎的调查[J] .实用医学进修杂志,2006,34(3):179-182
[21]徐小平,李卓成,艾辉,等.解脲支原体致非淋菌性尿道炎的研究[J] .中国卫生检验杂志,2005,15(9):1116-1117.
[22] Jennette M,PottsA,Michele Ward,Raymond R,Rackley.Association of Chronic Urinary Symptoms In Women And Ureaplasma urealy- ticum[J] . Urology,2000,55(4):486-489.
[23]李华,张洪文. .不同浓度解脲支原体血清型3在小鼠模型中的致病性研究[J] .中南大学,2008.
[24]江秀梅.178例阴道炎、宫颈炎患者解脲支原体感染状况分析[J] .疾病监测,2002,17(9):333.
[25]毛文奇.宫颈炎合并接触性出血与解脲支原体、沙眼衣原体感染的关系[J] .现代诊断与治疗,2005,16(6):362.
[26]张月莲,杨燕生.解脲支原体感染与输卵管性不孕的关系[J] .中华妇产科杂志,2000,35(2):110-111.
[27] PrabhakarK,SubramanianS,Thyagarajan SP.Mycoplasmahominis in pelvic inflammatory disease[J] .Indian J PatholMicrobiol,1994,37(3):293-298.
[28]刘建玲.慢性盆腔炎与沙眼衣原体及解脲支原体感染的关系[J] .临床心身疾病杂志,2007,13(3):252-253.
[29]黄跃深,黄志宏,王群,等.350例盆腔炎患者解脲支原体感染情况分析[J] .岭南皮肤性病科杂志,2006,13(2):94-95.
[30]韩茜,李秀荣,于占林等.不孕妇女生殖道支原体感染情况及药敏分析[J] .中国优生与遗传杂志.2004,12(5):122-123.
[31]陈永坚.不孕症妇女沙眼衣原体、解脲支原体感染的临床分析[J] .中国社区医师,2005,7(120):31.
[32]顾志芬.不孕不育妇女宫颈拭子解脲脲原体和人型支原体检测[J] .现代实用医学,2001,13(12):605.
[33] McGregor JA.French J I.Chlamydia trachomatis infection during pregnancy.Am J Obstet Gynecol,1991,6:1782-1789.
[34]张红霞,马远芳.解脲支原体感染与自然流产的关系[J] .中原医刊,1997,24(8):2-3.
[35] DesilvaN s,Quinn PA.Endogenous activity of phospholipaseA and C in ureaplasma urealyticum. J ClinMicrobiol,1986,23:354-359.
[36]潭巨莲,李进,孙辉臣,等.石家地区73例羊水解脲脲原体分离培养结果与临床分析[J] .中国优生与遗传杂志,1999,7(1):76 - 77.
[37] Lieselotte Kirchner,Hanns Helmer,Georg Heinze,et al.Amnionitis with Ureaplasma urealyticum or other microbes leads to increased morbidity and prolonged hospitalization in very low birth weight infants[J] .European Journal of Obstetrics & Gynecology and Reproductive Biology,2007,134:44-50.
[38] Embree JE,Krause VW,Embil VA,et al.Placental infection with mycopasma hom inis and urealyticum: clinical correction.Obstet Gynecol,1980,56:475-481.
[39]刘子韬,李丽娜,王俊松.宫内解脲支原体感染与新生儿出生体重[J] .白求恩医科大学学报,1998,24(5):482-484.
[40] A. Rempen , J. Martius,A. Hartmannet al.Transmission Rate of Ureaplasma Urealyticum,Mycoplasma spp,Gardnerella Vaginalis,B-Streptococci,Candida spp. and Chlamydia Trachomatis from the Mother to the Newborn.Arch Gynecol Obstet,1987,241:165-170.
[41] Stagno S, Brasfield DM, Brown MB, Cassell GH, Pifer LL, Whitley RJ, Tiller RE Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics,1981,68:322-329.
[42] Cassell, G. et al. Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns[J]. Clin. Microbiol, 1993,69-87.
[43]赵辨.《临床皮肤病学》(第三版).江苏:江苏科技出版社,2001,1106.
[44]范梦麟,唐孝亮,液体培养基培养解脲支原体效果评价[J].湖南医学高等专科学校学报,2001,3(1):24-25.
[45]陈志和,罗迪青,赖小敏.间接免疫荧光法检测解脲支原体[J].中国优生与遗传杂志,.2001,9(4):103-107.
[46]徐晨,钱黎华,王侠生等.培养及PCR法检测泌尿生殖道解脲支原体比较[J] .中国皮肤性病学杂志,1998,12(5):270-271.
[47]邱东海,徐静,汪秀荣.PCR杂交梳与培养检测解脲支原体的比较[J] .赣南医学院学报,2001,21(4):382-383.
[48]黄长征,林能兴,涂亚庭.阿奇霉素、氧氟沙星联合治疗解脲支原体所致非淋菌性尿道炎疗效观察[J] .华中医学杂志,2005,29(3):165-166.
[49]吴晓梅,戈静,余韬.纳米银与四环素联合治疗女性生殖道解脲支原体感染疗效观察[J] .中国妇产科临床杂志,2006,7(5):366.
[50]毛惠,戴晓蓉,詹平.中药内服外洗治疗妊娠中晚期解脲支原体感染60例[J] .中国中西医结合杂志,2006,26(7):663-665.
[51]郑华,钟淑霞,李明成.白头翁素联合铜绿治疗解脲支原体性非淋菌性尿道炎[J] .山东医药,2006,46(27):17-18.
[52]姜淑芬.奥平栓治疗支原体、衣原体感染及慢性宫颈炎的临床观察[J] .实用妇产科杂志,1998,14(3):163.
[53]王勤超,牛金波.交沙霉素联用重组人干扰素α-2b栓治疗解脲支原体感染性宫颈炎临床观察[J] .中国乡村医药杂志,2007,14(8):24.
[54] Jeff Wang.Bacterial Vaginosis[J] .Elsevier Science Inc,2000,7(5):181-185.
[55] Gardner HL,Dukes CD.Haemophilus vaginalis . A newly defined specificinfection previously classified ''Nonspecific'' vaginitis. Am J Obstet Gynecol,1955,69:962-76.
[56]樊尚荣,刘小平.细菌性阴道病的研究进展[J] .中国妇产科临床杂志,2006,7(3):224-226.
[57] Eschenbach DA,Davick PR,Williams BL,Klebanoff SJ,et al . Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis[J]. J Clin Microbiol,1989,27:251-6.
[58] Kimerlin DF,Andrews WW. Bacterial vaginosis: association with adverse pregnancy outcome[J]. SeminPerinatol,1998,22(4):1- 8.
[59]多丽波,郭薇媛,陈会.阴道加德纳菌[J] .哈尔滨医科大学学报,1998,32(1):76-79
[60]吴爱武,曹锦洪,刘岩平.阴道加德纳菌和细菌性阴道病相关性研究.临床皮肤科杂志,2000,29:324 - 325.
[61] Scott TG,Smyth CJ,Keane CT. In vitro adhesiveness and biotype of Gardnerella vaginalis strains in relation to the occurrence of clue cells in vaginal discharges.Genitourin Med,1987,63:47-53.
[62] Sobel JD. Vaginitis. New Engl J Med,1997,337:1896-903.
[63] Saidi SA,Mandal D,Curless E. Bacterial vaginosis in a district genitourinary medicine department: Significance of vaginal microbiology and anaerobes. Int J STD AIDS,1994,5:405-8.
[64] Mardh PA. The definition and epidemiology of bacterial vaginosis[J]. Rev Fr Gynecol Obstet,1993,88:195-7.
[65] Schoonmaker JN,Lunf BD,Lawellin DW,et al.A new proline aminopeptidase assay for diagnosis of bacterial vaginosis[J] .Am J Obstet Gynecol,1991,165:737.
[66] Ness RB,Hillier S,Richter HE,et al.Can known risk factors explain racialdifference in the occurrence of bacterial vaginosis[J] .J Natl Med Assoc,2003,95(3):201 - 212.
[67] Chiaffarino F,Parazzin I F,DeBesiP,et al.Risk factors for bacterial vaginosis [J] . Reprod Biol,2004,117(2):222-226.
[68]陈会波,周兰英,李会庆等.山东省农村地区已婚育龄妇女细菌性阴道病患病现状及危险因素[J] .国医学科学院学报,2006,28(3):378-381.
[69]毛淑芳,高玉峰.细菌性阴道病的危险因素研究现状[J] .中国公共卫生,2004,20(6):756-757.
[70] Alnaif B,Drutz HP.Bacterial vaginosis increase in pessary users[J] . Int Urogynecol J Pelvic Floor Dysfunct,2000,11(4):219 - 222.
[71] Hellberg D,Nilsson S,Mardh PA.Bacterial vaginosis and smoking[J] . Int J STD AIDS,2000,11(9):603 - 606.
[72] King EA,Britt R,McFarlane JM,et al.Bacterial vaginosis and chlamydia trachmatis among pregnant abused and nonabused His-panic women [J] . J Obste Gynecol Neonatal Nurs,2000,29(6):606 - 612.
[73]毛淑芳,金凤表,刘岩.产前检查妇女细菌性阴道病的筛检和相关危险因素的研究[J] .现代预防医学,2006,33(10):769-1771.
[74] Calzolari E,Masciangelo R,Milite V,et al.Bacterial vaginosis and contraceptive methods.Int J Gynecol Obstet,2000,70(3):341–346.
[75] Joesoef MR,Karundeng A,Runtupalit C,et al.High rate of bacteria vaginosis among women with intrauterine devices in Manado,Indonesia [J] . Contraception ,2001 ,64 (3) :169 - 172.
[76] Hodolugil NNS,Aslan D,Bertan M.Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence [J] . Contraception,2000,61(6):359 - 364.
[77] Morris MC,Rogers PA,Kinghorn GR,Is bacterial vaginosis a sexuallytransmitted infection [J] . Sex Transm Infect,2001,77(1):63 - 68.
[78] Kamara P,HyltonKong T,Brathwaite A,et al. Vaginal infections in pregnant women in Jamaica :prevalence and risk factors[J] . Int J STD AIDS,2000 ,11(8):516 - 520.
[79]俞树荣.微生物学和微生物学检验[M] .北京:人民卫生出版社,1997,263– 264.
[80] Spiegel CA, Amsel R, Holmes KR.Diagnosis of bacterial vaginosis is improved by direct gram stain of vaginal fluid. J Clin Microbiol,1983,18:170–7.
[81] Howe L,Wiggins R,Soothill PW,et al. Mueinase and sialidase activity of the vaginal microfilaria: imp lications of thepathogenesis of p reterm labour. Int J STD A IDS,1999,10(7):442-447.
[82]张卫英,项国谦,陈岳明等.BV Blue快速检测法对细菌性阴道病的诊断价值[J].浙江中西医结合杂志,2006,16(2):92-93.
[83]刘俊梅,杨文东,杨进国.快速脯氨酸氨基肽酶与唾液酸酶检测在细菌性阴道病诊断中的对比研究[J].中国妇产科临床杂志,2006,79(1):45-46.
[84]张海霞.细菌性阴道病的诊治进展[J].河北医药,2002,24(7):589-599.
[85] Amsel R, Totten PA, Spiegel CA.Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med,1983,74:14-22.
[86] Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by astandardized method of Gram stain interpretation. J Clin Microbiol,1991,29:297–301.
[87] Hillier SL. Diagnostic microbiology of bacterial vaginosis[J]. Am J Obstet Gynecol,1993,169:455–9.
[88] Morales WJ, Schorr S, Albritton J.Effect of metronidazole in patients withpreterm birth in preceding pregnancy and bacterial vaginosis:a placebo- controlled, double-blind study. Am J Obstet Gynecol,1994,171:345–9.
[89] Platz-Christensen JJ, Brandberg A, Wiqvist N. Increased prostaglandin concentrations in the cervical mucosa of pregnant women with bacterial vaginosis. Prostaglandins,1992,43:133-4.
[90] Cauci S , Hitti J , Noonan C , et al. Vaginal hydrolytic enzymes , Immunoglobulin A against Gardnerella vaginalis toxin , and risk of earlypreterm birth among women in preterm labor with bacterial vaginosis or intermediate flora[J] .1 AmJ Obstet Gynecol,2002,187:877-881.
[91] Carney FE.Haemophilus vaginalis septicaemia.Obstet Gynecol,1973,41:78-79.
[92] Gregory T Spear,Elizabeth St John,M Reza Zariffard.Bacterial vaginosis and human immunodeficiency virus infection[J].AIDS Research and Therapy 2007,4:25.
[93]张宣东,李光明,翁婉波。细菌性阴道病的发病情况及其诊断[J].海军医学杂志,2000,21(3):232-234.
[94]袁会敏,卞国玲,蒋丽娜.定君生与甲硝唑治疗细菌性阴道病的临床比较[J] .中国微生态学杂志,2006,18(3):251.
[95]石江平.α-干扰素栓治疗细菌性阴道病118例疗效观察[J] .实用临床医学,2006,7(1):90.
[1]曹玉璞,叶元康.支原体与支原体病[M].北京:人民卫生出版社, 2000.
[2] Vul,vovic luv,Rakovskaia IV,Gamova NA. The laboratory diagnosis of mycoplasmosis and ureaplasmosis in urological and gyneco- logicl patients [J]. Zh Mikrobial Epidemiol ,1995,5 :97
[3]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[4] Yoshida T , Ishiko H ,Yasuda M. Polymerase chain reaction based subtyping of ureaplasma parvum and ureaplasma urealyticum in firstpass urine samples from men with or without urethritis[J] . Sex Transm Dis,2005,32(7):454 - 457.
[5] Vikas Gupta,Benu Dhawan,Neena Khanna,et al. Detection and biovar discrimination of Ureaplasma urealyticum in Indian patients with genital tract infections[J] . Diagnostic Microbiology and Infectious Disease,2008,60(1):95-97.
[6] Abele-Hom M,Scholz M,Wolff C,et al. High-density vaginal Ureaplasma urealyticum colonization as a risk factor for chorioamnionitis and preterm delivery[J] . Acta Obstet Gynecol Scand,2000,79 (11):973 - 978.
[7] Chaic W,Horowitz S,Vavid J B,et al. Ureaplasma urealyticum in the development of postpartum endometritis[J] . Eur J Obstet Gynecol Reprod Biol,2003,1099(2):145 - 148.
[8]张帝开,覃春容,李秀云,等.女性下生殖道解脲支原体的定量检测与致病性研究[J] .中国实用妇科与产科杂志,2005,21(11):656 -658.
[9]樊尚荣,刘小平.细菌性阴道病的研究进展[J] .中国妇产科临床杂志,2006,7(3):224-226.
[10] Sobel JD.Vaginitis. New Engl J Med,1997,337:896-903.
[11] Carney FE.Haemophilus vaginalis septicaemia. Obstet Gynecol. 1973,41:78-79.
[12] Chiaffarino F,Parazzini F,De BesiP,et al. Risk factors for bacterial vaginosis [J] . REPROD. BIOL, 2004,117(2):222-226.
[13]陈会波,周兰英,李会庆等.山东省农村地区已婚育龄妇女细菌性阴道病患病现状及危险因素[J] .中国医学科学院学报,2006,28(3):378-381.
[14]毛淑芳,高玉峰.细菌性阴道病的危险因素研究现状[J] .中国公共卫生,2004,20(6):756-757.
[15] Alnaif B,Drutz HP. Bacterial vaginosis increase in pessary users[J] . Int Urogynecol J Pelvic Floor Dysfunct,2000,11(4):219 - 222.
[16] Hellberg D,Nilsson S,Mardh PA. Bacterial vaginosis and smoking[J] . Int J STD AIDS,2000,11(9):603 - 606.
[17] King EA,Britt R,McFarlane JM, et al. Bacterial vaginosis and chlamydia trachmatis among pregnant abused and nonabused His-panic women [J].J Obste Gynecol Neonatal Nurs,2000,29(6):606 - 612.
[18] Calzolari E,Masciangelo R,Milite V,et al. Bacterial vaginosis and contraceptive methods.Int J Gynecol Obstet,2000,70(3):341–346.
[19] Kamara P,HyltonKong T,Brathwaite A,et al. Vaginal infections in pregnant women in Jamaica :prevalence and risk factors[J] .Int J STD AIDS,2000,11(8):516 - 520.
[20]李沂轩,纪岩文.阴道加德纳菌的研究现状[J] .中国麻风皮肤病杂志,2006,22(4):319-321.
[21] Scott TG,Smyth CJ,Keane CT. In vitro adhesiveness and biotype of Gardnerella vaginalis strains in relation to the occurrence of clue cells invaginal discharges. Genitourin Med,1987,63:47-53.
[22] Mcgregor JA. Premature rupture of membranes and bacterial vaginosis [J] .Am Obstet Gynecol,1993,169:463.
[23]刘朝辉,张淑增,任翊.解脲支原体在正常人群宫颈的存在情况及分群分型[J] .中国实用妇科与产科杂志,2003,19(3):161-163.
[24]刘志强,张玲华,谷学英等.不同育龄妇女人群细菌性阴道病调查及临床分析[J].中国妇幼保健,2005,20:1394-1396.
[25] Dacca KR. Mycoplasma arthritidised derived superantigens induces proinflammatory monocytic cell live. Infection and Immunity,1994,62(6):2049.